超声引导下射频消融治疗单侧孤立性醛固酮瘤:一项两中心回顾性研究
该两中心回顾性研究纳入2020年1月至2024年6月接受超声引导下射频消融的单侧孤立性醛固酮瘤患者36例,评估技术成功、血压控制及并发症。全部患者单次消融成功并实现原发性醛固酮增多症完全生化缓解(36/36),高血压控制率66.7%(24/36),并发症率13.89%(5例),主要为术后感染所致发热。
要点
- 超声引导下射频消融治疗单侧孤立性醛固酮瘤单次技术成功率和完全生化缓解率均为36/36。
- 高血压控制率为66.7%(24/36),并发症率为13.89%(5例),以术后感染所致发热为主。
- 10例(27.8%)出现一过性血压显著升高,短期随访未见复发。
核心结论
- 该两中心研究提示,超声引导下射频消融对于经过选择的单侧孤立性醛固酮瘤患者是一种有效且安全的治疗选择。
研究设计与样本
- 两中心回顾性研究,纳入2020年1月至2024年6月在福州大学附属省立医院和中山大学附属第三医院接受超声引导下射频消融的醛固酮瘤患者36例(中位年龄49.5±5.3岁;男13例,女23例);评估技术成功(完全消融及术后3-6个月血清醛固酮-肾素比值正常化)、血压控制、并发症率及射频消融相关参数,采用重复测量方差分析比较消融前与各次随访的肿瘤体积变化。
诊断标准与关键数值
- 技术成功定义为完全肿瘤消融且术后3-6个月血清醛固酮-肾素比值(ARR)正常化,全部患者(36/36)单次消融成功并实现原发性醛固酮增多症完全生化缓解。
- 高血压控制率为66.7%(24/36)。
- 并发症率为13.89%(5例),主要为术后感染所致发热;10例(27.8%)出现一过性血压显著升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to evaluate the safety and efficacy of percutaneous ultrasound-guided radiofrequency (US-guided RFA) as a potential treatment for unilateral isolated Aldosterone-producing adenomas (APA). MATERIALS AND METHODS: Clinical data from patients with APA who underwent US-guided RFA between January 2020 and June 2024 at the Fuzhou University Affiliated Provincial Hospital and the Third Affiliated Hospital of Sun Yat-sen University were retrospectively analysed. Technical success (complete tumor ablation and normalization of the serum aldosterone-renin ratio [ARR] at 3-6 months post-RFA), blood pressure control, complication rates, and RFA-related parameters were assessed. Repeated-measures ANOVA was used to compare tumor volume changes before ablation and at each follow-up.
RESULTS: A total of 36 patients (Median age, 49.5±5.3 years; 13 men, 23 women) were evaluated. All patients achieved successful single-session ablation, with complete biochemical remission of primary aldosteronism (36/36). The hypertension control rate was 66.7% (24/36). The complication rate was 13.89% (five patients), primarily fever caused by postoperative infection. A transient significant increase in blood pressure occurred in 10 patients (27.8%). No short-term recurrence was observed.
CONCLUSION: This two-centre study provides evidence that US-guided RFA is an effective and safe treatment option in selected patients with unilateral isolated APA.
引用
- Tang L, Li K, Yang J, et al. Ultrasound-Guided Radiofrequency Ablation for Unilateral Isolated Aldosterone-Producing Adenoma: A Two-centre Retrospective Study. Acad Radiol. 2025. PMID: 40664561. doi:10.1016/j.acra.2025.06.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。